publications-2011-2013

Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients

Published on 19 March 2015

Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients
Authors	Chabre O, Libe R, Assie G, Barreau O, Bertherat J, Bertagna X, Feige JJ, Cherradi N
Journal	Endocr.-Relat. Cancer 20 (4), 579-594, 2013
Year	2013
Institute	iRTSV

Retour à la liste

Top page

Alternative and Atomic Energies Agency

CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.

The Knowledge Factory

In the same section :

Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients

Browse the site

Alternative and Atomic Energies Agency

Browse the portal

The Knowledge Factory

About Fundamental Research Division

Research fields

Scientific results

In the same section :

Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients

Browse the site

Alternative and Atomic Energies Agency

Browse the portal